C21 Investments Inc 6-K, filed Feb 14, 2022
C21 Investments Inc. (CWLXF)
About this 6-K
C21 Investments Inc filed this 6-K on February 14, 2022.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of February, 2022
Commission File Number: 000-55982
C21 Investments Inc.
(Translation of registrant's name into English)
Suite 1900-855 West Georgia St., Vancouver, BC, V6C 3H4
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
[ ] Form 20-F [ x ] Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]
SUBMITTED HEREWITH
Exhibits
| 99.1 | CSE Form 11 Options issuance | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| C21 Investments Inc. | ||
| (Registrant) | ||
| Date: February 11, 2022 | By: | /s/ Michael Kidd |
|
|
||
| Michael Kidd | ||
| Title: | CFO | |
FORM 11
NOTICE OF PROPOSED STOCK OPTION GRANT OR AMENDMENT
Name of Listed Issuer: C21 INVESTMENTS INC. (the "Issuer").
Trading Symbol: CXXI
Date: February 10, 2022
1. New Options Granted:
Date of Grant: February 10, 2022
| Name of Optionee | Position (Director/officer/ employee/consultant) |
Insider Yes or No? |
No. of Optioned shares |
Exercise Price |
Expiry Date | Options granted in the last 12 months |
| Bruce Macdonald | Chairman | Yes | 200,000 | $ 0.70 | Feb 10 2025 | Nil |
| CB1 Capital Advisors | Consultant | No | 200,000 | $ 0.70 | Feb 10 2025 | Nil |
| Michael Kidd | CFO, Director | Yes | 200,000 | $ 0.70 | Feb 10 2025 | Nil |
| Total Number of optioned shares proposed for acceptance | 600,000 | |||||
2. Other Presently Outstanding Options:
| No. of optioned shares | Exercise Price | Original date of grant |
Expiry date |
| 150,000 | $ 0.70 | Jan 28, 2021 | Jan 28, 2024 |
| 3,905,000 | $ 0.70 | Aug 17, 2020 | Aug 17, 2023 |
| 100,000 | $ 0.80 | Jan 24, 2020 | Jan 24, 2023 |
| 500,000 | $ 1.00 | Oct 10, 2019 | Oct 10, 2024 |
| 500,000 | $ 1.38 | Oct 10, 2019 | Oct 10, 2022 |
(1) Set out number of optioned shares for each grant with different terms.
3. Additional Information
(a) If shareholder approval was required for the grant of options (including prior approval of a stock option plan), state the date that the shareholder meeting approving the grant was or will be held. N/A
(b) State the date of the news release announcing the grant of options. N/A
(c) State the total issued and outstanding share capital at the date of grant or amendment. 120,047,814
(d) State, as a percentage of the issued and outstanding shares of the Issuer indicated in (c) above, the aggregate number of shares that are subject to incentive stock options, including new options, amended options and other presently outstanding options: 4.8%
(e) If the new options are being granted pursuant to a stock option plan, state the number of remaining shares reserved for issuance under the plan: 6,249,781
(f) If the Issuer has completed a public distribution of its securities within 90 days of the date of grant, state the per share price paid by the public investors. N/A
(g) Describe the particulars of any proposed material changes in the affairs of the Issuer. N/A
4. Certificate of Compliance
The undersigned hereby certifies that:
1. The undersigned is a director and/or senior officer of the Issuer and has been duly authorized by a resolution of the board of directors of the Issuer to sign this Certificate of Compliance.
2. As of the date hereof there is no material information concerning the Issuer which has not been publicly disclosed.
3. The undersigned hereby certifies to the Exchange that the Issuer is in compliance with the requirements of applicable securities legislation (as such term is defined in National Instrument 14-101) and all Exchange Requirements (as defined in CNSX Policy 1).
4. All of the information in this Form 11 Notice of Proposed Stock Option Grant or Amendment is true.
Dated: February 10, 2022
SIGNED: "Michael Kidd"
Michael Kidd, CFO, Secretary,
Director